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Epilysin (MMP-28) is the newest member of the
matrix metalloproteinase enzyme family. Several
members of this enzyme family have been associated
with various aspects of wound repair and cancer
invasion. The aim of this study was to characterize
in different types of wounds, skin cancers, and kera-
tinocyte cultures factors that contribute to epilysin
expression in vivo, as well as how and where it is
induced in relation to other matrix metalloprotei-
nases. Our results indicate that epilysin is produced
by the mitotic Ki-67-positive keratinocytes distal
from the wound edge in both acute and chronic
wounds and that it does not generally colocalize with
collagenase-1, stromelysin-2, or 92 kDa gelatinase in
migrating keratinocytes. An injury of epidermis was
needed for epilysin induction as it was upregulated
in ulcerated pyogenic granulomas and in suction
blisters but was not detected in intact acanthotic or
normal skin. Unlike many other matrix metallopro-
teinases, epilysin was not detected in the invading
cancer cell nests of sclerosing basal or squamous cell
cancers of various grades. When primary keratino-
cytes were stimulated with tumor necrosis factor a,
upregulation of epilysin mRNA was evident within
24±48 h as measured by quantitative reverse tran-
scription polymerase chain reaction. In primary ker-
atinocyte, HaCaT, and A431 carcinoma cell cultures
none of the 10 other growth factors or extracellular
matrices studied were able to upregulate epilysin
expression. Our results suggest that epilysin expres-
sion is tightly spatially and temporally regulated dur-
ing wound repair. Although the in vivo substrates of
epilysin are not known at present, its expression pat-
tern suggests that it may be needed to restructure
the basement membrane or to degrade adhesive
proteins between keratinocytes to supply new cells
for the migrating front. Key words: cancer/laminin-5/
wound healing. J Invest Dermatol 119:14±21, 2002
T
he matrix metalloproteinase (MMP) enzyme family
nowadays comprises more than 20 members capable
of degrading most extracellular matrix proteins
(Nagase and Woessner, 1999; Uria and Lopez-Otin,
2000). Epilysin (MMP-28), the newest member of this
family, was ®rst cloned from human keratinocyte and testis cDNA
libraries (Lohi et al, 2001) and also from a lung cDNA library
(Marchenko and Strongin, 2001). It is a 59 kDa protein and three
different transcripts (2.6, 2.0, and 1.2 kb) can be detected in various
tissues due to alternative splicing by northern analysis (Lohi et al,
2001). Although hybridization of multiple tissue northern blots
indicated that MMP-28 mRNA is expressed at high levels in testis
and at lower levels in normal human lung, heart, colon, intestine,
and brain, RNAse protection assays with various cell lines indicated
that epilysin was selectively expressed by keratinocytes in culture.
By reverse transcription polymerase chain reaction (RT-PCR)
ampli®cation it has been detected in several fetal tissues (lung, brain,
skeletal muscle, and kidney) and in adult kidney and pancreas
(Marchenko and Strongin, 2001). Comparison of the amino acid
sequence of MMP-28 with the other MMPs indicated that it is
most closely related to certain other recently cloned members of the
family, such as MMP-19 (Lohi et al, 2001; Marchenko and
Strongin, 2001). No physiologic substrates or activators of MMP-
28 have been identi®ed yet, however, although it has been shown
to cleave casein in vitro (Lohi et al, 2001).
Several MMPs have been implicated in cutaneous wound
healing during which they are strictly spatially and temporally
regulated. Collagenase-1 (MMP-1), stromelysin-2 (MMP-10), and
92 kDa gelatinase (MMP-9) are expressed by migrating keratino-
cytes, whereas stromelysin-1 (MMP-3) is produced in keratinocytes
just behind the migrating cells (see Parks, 1999). The same MMPs
also participate in cancer cell migration occurring in basal and
squamous cell cancers (see KaÈhaÈri and Saarialho-Kere, 1999;
KerkelaÈ et al, 2001). Epilysin has been detected by PCR
ampli®cation in colon, pancreatic, and ovarian adenocarcinomas,
and in prostate and lung cancer cell lines (Marchenko and Strongin,
2001). Furthermore, immunostaining of ex vivo wounds in cell
culture has revealed that epilysin is induced during epithelial repair
(Lohi et al, 2001). The aim of this study was to better de®ne the
role and cellular origin of epilysin in epithelial repair and skin
cancer. We have analyzed epithelial tissues and speci®c cell types
that express MMP-28 in vivo, which is an important step in
elucidating the physiologic functions of this proteinase. We observe
that during wound repair epilysin expression is tightly regulated. It
is produced by the proliferating keratinocytes behind the migrating
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cells in an area where intracytoplasmic laminin-5 (LN-5), a marker
for migrating keratinocytes (Larjava et al, 1993), becomes con®ned
to the basement membrane (BM) zone. Furthermore, unlike most
other MMPs, epilysin does not seem to be induced in aggressive
subtypes of basal or squamous cell carcinoma of the skin.
MATERIALS AND METHODS
Tissues Informed consent was obtained from individual subjects for all
procedures. The study was approved by the Ethics Committees of the
Departments of Dermatology and Plastic Surgery, Helsinki University
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Central Hospital. Formalin-®xed, paraf®n-embedded archival specimens
from adult patients were obtained from the Department of
Dermatopathology, Skin and Allergy Hospital, University of Helsinki.
The following specimens were examined: normal skin (n = 4), ulcerated
and nonulcerated pyogenic granulomas (n = 5), basal cell cancers
(sclerosing subtype; n = 7), squamous cell carcinomas (grades II and III;
n = 9), lichenoid eczema (n = 4), chronic wounds (n = 15), normally
healing timed wounds (n = 9), and suction blisters (n = 12). Suction
blisters were induced on healthy abdominal skin and harvested at 2, 4,
and 9 d as previously described (Vaalamo et al, 1999). Samples of 15
chronic ulcers of various etiologies were collected from patients at the
Department of Plastic Surgery undergoing excision and grafting for
nonhealing ulcers. Five biopsies from clinically well granulating ulcers,
that required skin grafting because of their large size, were also
examined. Biopsies of normally healing donor areas of anterior thigh
were obtained 1±9 d after wounding from nine patients of the
Department of Dermatology undergoing pinch grafting, and they served
as samples of normally healing wounds (Vaalamo et al, 1996).
Immunohistochemistry Immunostaining was performed by the
avidin-biotin-peroxidase technique (Vectastain ABC Kit, Vector
Laboratories, Burlingame, CA) as described previously (Saarialho-Kere et
al, 1993; Rechardt et al, 2000) using pretested dilutions of af®nity-
puri®ed epilysin rabbit antibodies (1:700; Lohi et al, 2001).
Diaminobenzidine or aminoethylcarbazole were used as chromogenic
substrates and Harris hematoxylin as counterstain. The sections were
pretreated by antigen retrieval as described previously (Von Boguslawski,
1994) and endogenous peroxidase was inactivated by 0.3% H202 for
30 min. A monoclonal Mib-1 antibody (1:500; 0505, Immunotech,
Marseilles, France), which reacts with the Ki-67 nuclear antigen, was
used to differentiate proliferating cells from quiescent epithelial cells. A
monoclonal antibody to type IV collagen (1:75; M785, Dako, Glostrup,
Denmark) was used to stain the BM. MMP-9 was detected using a
monoclonal antibody (1:500; GE213, Diabor, Oulu, Finland). LN-5-
producing cells were identi®ed with polyclonal rabbit antibodies against
the gamma2 chain of LN-5 (1:600; a gift from Professor Karl
Tryggvason, Karolinska Institutet). For negative controls, we processed
sections with preimmune serum, or we coincubated af®nity-puri®ed
antibodies with excess peptide antigen to inhibit speci®c interactions
with epilysin in the tissue.
In situ hybridization In situ hybridization using 35S-labeled probes for
MMP-1, MMP-3, and MMP-10 was performed as previously described
(Prosser et al, 1989; Rechardt et al, 2000).
Cell cultures Human keratinocytes were obtained from seven patients
undergoing reductive mammoplasties as described previously (Rechardt
et al, 2000) and cultured in keratinocyte growth medium (KGM, Gibco
BRL, Life Technologies, Paisley, U.K.), supplemented with 5 ng per ml
epidermal growth factor (EGF) and 50 mg per ml bovine pituitary
extract. A431 cells (epidermoid carcinoma cell line, ATCC) and HaCaT
cells (Boukamp et al, 1988), transformed human epidermal keratinocytes,
were cultivated in Dulbecco's modi®ed Eagle's medium (DMEM, Gibco
BRL) containing 10% fetal bovine serum, 1% penicillin±streptomycin,
and 1% sodium pyruvate.
Cytokines, growth factors, and matrices To study the regulation of
epilysin expression, equal amounts of cells were plated on 24-well tissue
culture plates. On the next day, the cells were repeatedly washed with
phosphate-buffered saline and incubated in serum-free medium without
supplements for 12±24 h. Analogously, all treatments were carried out
without serum. The cells were subsequently treated with basic ®broblast
growth factor (bFGF) (10 ng per ml, Oncogene, Calbiochem, Boston,
MA), EGF (10 ng per ml, Sigma, St. Louis, MO), granulocyte±
macrophage colony stimulating factor (GM-CSF) (10 ng per ml, R&D
Systems, Minneapolis, MN), hepatocyte growth factor (HGF) (20 ng per
ml, Sigma), interferon-g (IFN-g) (20 ng per ml or 100 U per ml, Sigma),
interleukin-1b (IL-1b) (10 ng per ml, Roche Molecular Biochemicals,
Mannheim, Germany), keratinocyte growth factor (KGF) (10 ng per ml,
Sigma), platelet-derived growth factor (PDGF) (20 ng per ml, Sigma),
transforming growth factor b1 (TGF-b1) (5 ng per ml, Sigma), tumor
necrosis factor a (TNF-a) (20 ng per ml, Sigma), vascular endothelial
growth factor (VEGF) (10 ng per ml; 293-VE, R&D Systems), and
insulin-like growth factor 1 (IGF-1) (100 ng per ml; 291-G1, R&D
Systems) for 24 or 48 h. Untreated cells were used as a control.
To characterize the role of the growth substratum, cells were
cultivated on tissue culture dishes coated with different matrices, includ-
ing collagen I, collagen IV, laminin, ®bronectin, and Matrigel (Becton-
Dickinson, Bedford, MA). Matrigel was diluted 1:10 using serum-free
medium according to the manufacturer's instructions. After 24 or 48 h
total RNA was extracted from the cells. All treatments were carried out
in triplicate, and the results were con®rmed in at least two independent
experiments. For immunostaining, HaCaT cells and primary keratino-
cytes (in both KGM and DMEM) were also cultured on Laboratory-Tek
chamber slides (plastic or type I collagen coated) and treated with TNF-
a and KGF where indicated.
Quantitative RT-PCR PCR primers (Sigma Genosys, Cambridge,
U.K.) and probes (PE Biosystems, Warrington, U.K.) for epilysin were
designed using the computer program Primer Express (PE Biosystems).
Primers used for ampli®cation were 5¢-GGCGTAAGAAACGCTT-
TGCA-3¢ (forward, nucleotides 765±784) and 5¢-CAGTTCACCAG-
GCGGTAGGA-3¢ (reverse, nucleotides 834±816). Fluorogenic probes
contained a reporter dye (FAM) covalently attached at the 5¢ end and a
quencher dye (TAMRA) covalently attached at the 3¢ end. Human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) labeled with VIC
reporter dye (Pre-developed TaqMan Control Reagents, PE Biosystems)
was used as an endogenous control in PCR. Stromelysin-2, which can
be induced by TGF-b1 in cultured keratinocytes, was used as a positive
control as described previously (Rechardt et al, 2000).
Total cellular RNA from cell cultures was extracted by using RNeasy
miniprep-kit (Qiagen, Chatsworth, CA) according to the manufacturer's
instructions. RNA was then reverse transcribed to cDNA with TaqMan
Multiscribe enzyme and random hexamers and used as a template in
PCR. Real-time quantitative PCR were performed with the ABI
PRISM 7700 Sequence Detector System (PE Biosystems) as previously
described (Rechardt et al, 2000). PCR ampli®cations were performed in
a total volume of 20 ml, containing 5 ml cDNA sample, 1 ml human
GAPDH endogenous control reagents, 100 nm of each primer, and
100 nm of ¯uorogenic probe. The PCR was started with 2 min at 50°C
and an initial 10 min denaturing temperature of 94°C, followed by a
total of 40 cycles of 15 s of denaturing and 1 min of annealing and
elongation at 60°C.
RESULTS
Expression of epilysin during normal wound healing In
normally healing pinch graft wounds epilysin was detected in basal
and suprabasal keratinocytes distal from the migrating edge
(Fig 1A). In situ hybridization of serial sections indicated that the
epilysin-positive epidermis overlapped with the distal tip of MMP-
1-positive cells to some extent (Fig 1B); however, epilysin-positive
cells reached much further away from the wound edge. MMP-10
mRNA (Fig 1C) or MMP-9 protein (data not shown) were
expressed by the migratory tip and did not colocalize with epilysin.
LN-5, which is an adhesive ligand in epithelial BM and produced
by migrating keratinocytes (Larjava et al, 1993), was used as a
Figure 1. Epilysin is differentially expressed from other MMPs in normally healing wounds. (A) Immunostaining for epilysin in a 4-d-old
wound. (B) In situ hybridization for MMP-1. (C) In situ hybridization for MMP-10. Black arrow marks the distal tip of MMP-10 signal. (D)
Immunostaining for LN-5. Arrows mark corresponding spots (A±D). U indicates the ulcer area. (E) Re-epithelialization occurring from a hair follicle
with positive staining for epilysin (arrows). (F) Normal skin. Counterstaining with hematoxylin (A, D±F) and hematoxylin±eosin (B, C). Scale bar:
40 mm.
Figure 2. Epilysin protein is detectable in proliferating keratinocytes residing also on an intact BM. (A) Immunostaining for epilysin in a 1-
mo-old rheumatoid ulcer. Immunostainings for type IV collagen (B) and Ki-67 proliferation marker (C) were carried out on nearby sections. In situ
hybridizations for MMP-1 (D) and MMP-10 (E). Arrows mark corresponding spots. U marks the ulcer area. (F) Immunostaining for epilysin in an
ulcerated pyogenic granuloma. (G) Immunostaining for Ki-67 in the same sample. Counterstaining with hematoxylin (A±C, F, G) and hematoxylin±
eosin (D, E). Scale bar: 40 mm.
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marker. Intracellular staining for LN-5 partly overlapped with the
area of epilysin-positive keratinocytes (Fig 1A, D), suggesting that
the keratinocyte phenotype changed from migratory to stationary
in this region. Also, when re-epithelialization had started from hair
follicles, the pattern of epilysin protein expression was con®ned
distal to the migrating tips (Fig 1E). No epilysin was
immunodetected in normal skin (Fig 1F). The epithelial
structures of the samples were always negative in controls
performed with either preimmune serum or incubation with
neutralizing excess of peptide antigen (Fig 3C).
In larger well-granulating wounds several weeks old, epilysin was
detected in basal and partly suprabasal keratinocytes away from the
migrating edge (Fig 2A) over a greater length of epidermis
compared to that seen in acute wounds. Epilysin expression
coincided with the area where BM type IV collagen started to show
an intact pattern by immunostaining (Fig 2B). Epilysin did not
colocalize with MMP-10 mRNA or MMP-9 protein in these
wounds (Fig 2E and data not shown), but it overlapped with the
distal front of MMP-1-positive cells to some extent (Fig 2D). In
both wounds and pyogenic granulomas, the epilysin-positive area
was clearly hyperproliferative as assessed by Ki-67 staining (Fig 2A,
C, F, G). Strong intracellular LN-5 staining, characteristic for
migrating epithelial cells of the wound margin, was usually absent
from epilysin-positive areas in both chronic cutaneous wounds
(diabetic, decubitus, rheumatoid) (Fig 3A, B) and ulcerated
pyogenic granulomas (data not shown).
Epilysin in suction blisters To understand whether epilysin can
be induced in keratinocytes without a direct contact with
underlying extracellular matrix, suction blisters harvested at 2, 4,
and 9 d were studied. If the blister roof was left intact, epilysin was
detected at some basal and suprabasal keratinocytes distal from the
migrating tip at day 2 (Fig 3D). Epilysin was abundantly expressed
by proliferating basal and suprabasal keratinocytes in both types of 4
d blisters, however. Epilysin-positive keratinocytes were generally
not positive for LN-5 intracellularly (Fig 3E, G), and they resided
on an intact BM as assessed by type IV collagen staining (Fig 3E,
F). As in acute wounds, MMP-9 and MMP-10 mRNAs did not
colocalize with epilysin (data not shown). Epilysin was not detected
any more in the basal keratinocytes of re-epithelialized 9 d blisters
(data not shown).
Epilysin in skin cancers No immunosignal for epilysin could be
detected in basal keratinocytes of benign hyperproliferative skin
disorders such as lichenoid eczema characterized by acanthotic
Figure 3. Epilysin-expressing cells are not migrating as assessed by LN-5 immunostaining and the protein is induced in suction blisters.
(A) Immunostaining for epilysin in a well-granulating 2-wk-old post-traumatic wound. (B) Staining for LN-5 in the same sample. Note the change of
LN-5 immunostaining from intracellular to BM-like in the epilysin-positive area. (C) Negative control for epilysin immunostaining performed by
coincubating af®nity-puri®ed antibodies with excess peptide antigen. Arrows depict corresponding spots. U marks the ulcer area. A 2 d suction blister
immunostained for epilysin (D). Arrows depict area of positive cells. A 4 d suction blister immunostained for epilysin (E), type IV collagen (F), and LN-
5 (G). Counterstaining with hematoxylin (A±G). Scale bars: (A)±(C), (E)±(G) 40 mm; (D) 20 mm.
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hyperproliferative epidermis (Fig 4A, inset a), suggesting that tissue
injury is needed for epilysin induction. Epilysin was not detected in
aggressive cutaneous sclerosing basal (Fig 4B) or squamous cell
carcinomas (grades II and III) either. In four grade I squamous cell
carcinomas that had arisen in chronic ulcers, however, epilysin
could be detected in proliferating basal and suprabasal keratinocytes
in the ulcerated area (Fig 4C, D). We also immunostained these
samples for MMP-9 and found that it was present not in the
epilysin-positive epithelium but deeper in epithelial cancer islands
(data not shown). In contrast to results with various other cancer-
associated MMPs including MMP-1, MMP-2, MMP-11, and
MMP-13 (Airola et al, 1997; Johansson et al, 1999), epilysin was not
detected in small invading cancer cell nests (Fig 4C±F).
Epilysin was detected in the cytoplasm of HaCaT cells cultured
on Laboratory-Tek chamber slides (Fig 5A). When keratinocytes
cultured on collagen I in DMEM were wounded, no staining was
detected in migrating cells, supporting our in vivo observation that
epilysin expression is associated with proliferating but not with
migrating keratinocytes (Fig 5C, D).
Regulation of epilysin mRNA in epidermal cells in vitro To
study the regulation of epilysin expression, we cultured primary
keratinocytes isolated from seven different patients, transformed
HaCaT cells, and A431 cells in the presence of various growth
factors and cytokines and used quantitative real-time RT-PCR for
analysis. Basal levels for epilysin mRNA in A431 cells were quite
low, as it was detected only at cycle 31, whereas in HaCaT cells and
human epidermal keratinocytes it was found already at cycles 26±
27. None of the cytokines or growth factors studied (bFGF, EGF,
GM-CSF, HGF, IFN-g, IL-1b, KGF, PDGF, TGF-b1, VEGF,
IGF-1) signi®cantly upregulated the production of epilysin
mRNA. TGF-b showed a slight inductive tendency, but the
induction did not exceed 2.0-fold (Fig 6), which is considered the
smallest signi®cant value in the Taqman analysis. In contrast,
signi®cant upregulation of epilysin mRNA was seen when primary
keratinocytes were stimulated with TNF-a (Fig 6). After this
®nding, we also studied the effect of this cytokine in subcon¯uent
keratinocyte cultures and saw that the TNF-a upregulation was
even higher than in con¯uent cells. Furthermore, stronger
immunostaining of TNF-a treated cells cultured on Laboratory-
Tek chamber slides compared with unstimulated control cells was
observed (Fig 5E±G). When cultured cells were stimulated by
KGF, cell proliferation was evident but no changes in
immunostaining for epilysin were observed compared to
unstimulated cells (data not shown). Direct contacts between the
cells and components of the extracellular matrix did not induce the
production of epilysin, as analyzed by cells cultured on collagens I
or IV, ®bronectin, laminin-1, or the BM matrix Matrigel. Our
results were con®rmed in several experiments, and growth factor
responsiveness was observed in every experiment. A clear induction
of MMP-10 was observed in each Taqman run in keratinocytes
treated with TGF-b1 (Rechardt et al, 2000).
DISCUSSION
In this work we ®nd that epilysin is produced in vivo by
nonmigrating, proliferating keratinocytes in response to skin injury.
It is generally not expressed by the same keratinocyte population
that synthesizes MMP-1, MMP-9, and MMP-10, thus emphasizing
the strict spatial and temporal regulation of different MMPs during
epithelialization (Fig 7). Much like epilysin, MMP-3 is expressed
just behind the migrating front by keratinocytes still in contact with
the underlying BM (Saarialho-Kere et al, 1994). MMP-3 is known
to activate several other MMPs, and this cannot be excluded in the
case of epilysin either.
Epilysin is a secretory MMP. Its in vivo substrates or activators are
not known at present. Unlike in this study, Lohi et al (2001) found
epilysin also in migrating keratinocytes. This may be due to the use
Figure 4. Epilysin is not expressed in
invasive cancer cells. (A) Negative basal cell
immunostaining for epilysin in a sample of
lichenoid eczema with prominent acanthosis. Inset
a: Higher magni®cation of epilysin-negative basal
cell area. (B) Negative immunostaining for
epilysin in a basal cell cancer. (C) Positive basal
cell staining for epilysin at the surface epithelium
of a well-differentiated squamous cell carcinoma
developed from a chronic wound. (D) Immuno-
staining for Ki-67 in the same sample. Arrows
depict corresponding spots. (E) Immunostaining
for epilysin in an ulcerated area of another
squamous cell carcinoma developed from a
chronic wound. (F) Immunostaining for LN-5.
Arrows depict epilysin-negative, but LN-5-
positive, cancer islands. Counterstaining with
hematoxylin (A±F). Scale bars: (A)±(D) 20 mm;
(E), (F) 40 mm.
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of ex vivo explants in culture and not wound biopsies. Although
these ex vivo wounds mimic the MMP expression of normal wound
repair in many respects (Pilcher et al, 1997), differing culture
conditions and the lack of necrosis and thrombosis may modify
MMP expression.
In addition to cell±matrix and cell±cell interactions (Saarialho-
Kere et al, 1993), soluble factors present within the extracellular
matrix may also play an important role in regulating the expression
of MMPs by keratinocytes. Our results indicate that the expression
of epilysin in cultured keratinocytes cannot be induced by
keratinocyte mitogens such as EGF, bFGF, KGF, or IGF-1, or
by HGF, IFN-g, IL-1b, VEGF, PDGF, or TGF-b1 in vitro. The
results were similar in both normal and immortalized (HaCaT) as
well as transformed keratinocytes (epidermoid carcinoma A431).
All the tested cytokines are instrumental in wound repair and
variably upregulate MMP-1, MMP-3, MMP-9, and MMP-10 in
keratinocytes during epithelialization (Salo et al, 1994; Dunsmore et
al, 1996; Pilcher et al, 1997; Rechardt et al, 2000). In contrast,
TNF-a constantly upregulated epilysin in primary keratinocytes
obtained from several different patients.
TNF-a is a multifunctional pro-in¯ammatory cytokine that is
mainly produced by macrophages. It is an angiogenic factor and
capable of, for example, inhibiting tumor growth (Feiken et al,
1995). Expressed by neutrophils and macrophages subadjacent to
the wound clot (Feiken et al, 1995), it is an important mediator
during the in¯ammatory phase of wound healing and stimulates the
secretion of several MMPs during skin repair (Han et al, 2001).
TNF-a is also known to enhance invasive migration and
mitogenesis of ®broblasts, and it in fact upregulates KGF gene
expression in these cells, which may ultimately signal keratinocytes
to proliferate (Tang and Gilchrest, 1996). In keratinocyte cultures
TNF-a is not a mitogen but inhibits cell proliferation when
Figure 6. Epilysin mRNA expression is induced by TNF-a in
primary keratinocytes. Cells were cultured in KGM and stimulated
with the cytokines and growth factors indicated for 24 h. Total RNA
was extracted, reverse transcribed, and analyzed by real-time quantitative
RT-PCR (Taqman, PE Biosystems) using GAPDH as an endogenous
control. Results are illustrated relative to the mRNA levels of control
cells. Epilysin induction by TNF-a was much more prominent in
subcon¯uent (70%) than con¯uent cells.
Figure 5. Migrating cells in culture are
devoid of epilysin. (A) Intracytoplasmic staining
for epilysin in cultured HaCaT cells. (B) Negative
control (preimmune serum). (C) Keratinocytes (in
DMEM) cultured on type I collagen at the
migrating front do not express epilysin. (D)
Immunostaining for Ki-67 in an adjacent
chamber. Arrows depict the wounded area and the
migration direction of the cells. (E) Epilysin
staining of unstimulated primary keratinocytes
cultured on plastic. (F) TNF-a-treated keratino-
cytes with enhanced staining. (G) Negative
immunocontrol (preimmune serum). Aminoethyl-
carbazol was used as chromogenic substrate and
counterstaining was performed with hematoxylin
(A±G). Scale bars: (A) 10 mm; (C), (E)±(G)
20 mm; (B), (D) 40 mm.
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administered for several days (Pillai et al, 1989). This contrasts with
our ®ndings in vivo showing the expression of MMP-28 in Ki-67-
positive cells. One of the explanations for this discrepancy could be
that there exist many examples where in vivo epidermal
keratinocytes respond to cytokine expression in a fashion quite
distinct from that observed in vitro (Turksen et al, 1992).
According to our immunostaining results, epilysin is not
associated with the migration of keratinocytes in skin cancers.
Epithelial cells in both squamous cell carcinomas and adenocarci-
nomas of the lung produce epilysin, however (Saarialho-Kere et al,
unpublished). This may be due to a speci®c cell type and/or tissue
type governing its expression, which is a typical feature for many
MMPs such as matrilysin (Dunsmore et al, 1998). Interestingly, the
closely related metalloenzyme MMP-19 is not associated with
invasive phenotype and neoplastic dedifferentiation (Djonov et al,
2001), and thus seems to possess the same kind of biologic pattern
during transformation of mammary epithelium as epilysin has in
skin cancer progression.
The promoter of epilysin contains a functional GT-box/Sp1 site
that is necessary for basal promoter activity (Illman et al, 2001).
Among other MMPs, also MMP-2, MMP-9, MT1-MMP, and
MMP-19 promoters have similar elements (Mohan et al, 1998; Lohi
et al, 2000; Muller et al, 2000; Price et al, 2001). In fact, Sp1
transcription factor is selectively induced in the corneal epithelium
migrating to heal a wound (Mohan et al, 1998), and during
cutaneous wound repair epilysin may also be regulated through this
transcriptional pathway. TNF-a upregulates 92 kDa gelatinase in
human skin through the NF-kB pathway (Han et al, 2001) and this
cascade may mediate the induction of epilysin even though its
promoter has not been reported to contain a consensus NF-kB
binding site.
In agreement with the behavior of MMP-3, MMP-9, and
MMP-10 in keratinocytes (Sudbeck et al, 1997), epilysin expression
was not modulated by matrices in cell culture. Analogously,
epilysin was upregulated in vivo in suction blisters despite the fact
that in them keratinocytes are not in direct contact with dermal
matrices (Kainulainen et al, 1998). Therefore, contact with a
speci®c extracellular matrix component is not a prerequisite for
epilysin induction, which is turned off soon after completion of re-
epithelialization.
LN-5 immunohistochemistry was performed to investigate the
migratory phenotype of epilysin-positive epithelial cells (Larjava et
al, 1993). Intracellular staining for LN-5 re¯ects active synthesis of
this protein needed for the deposition of normal BM and is usually
encountered in migrating cells of suction blisters and acute wound
edges (Kainulainen et al, 1998; Rechardt et al, 2000). Based on our
serial specimens, keratinocytes expressing epilysin do not seem to
be migratory. Instead, LN-5 staining becomes con®ned to the BM
(Fig 4B) in the epilysin-positive areas of the epidermis. Cleavage of
the precursor molecule to mature LN-5, needed for hemidesmo-
some assembly, may signal the epithelial cells to become quiescent
and form integrated tissue (HaÈkkinen et al, 2000). Unfortunately,
our antibody does not distinguish between mature and precursor
LN-5. To date, MMP-2 and MMP-14 are the only metalloen-
zymes known to cleave LN-5 in vitro (Giannelli et al, 1997;
Koshikawa et al, 2000). Whether epilysin also belongs to that group
awaits further studies.
Although the physiologic substrates of epilysin have not been
identi®ed yet, its expression pattern suggests that it may be needed
to restructure the newly formed BM. Keratinocytes at the wound
edge of tissue damage augment their basal proliferating phenotype,
supplying new cells for the migrating front. Thus it may be that
none of the BM components is the substrate of epilysin but that it is
needed to degrade adhesive proteins like cadherins or type XIII
collagen to release new cells for the migrating front.
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